Concert Pharmaceuticals just posted positive topli
Post# of 148165
(Total Views: 674)
Posted On: 05/23/2022 11:26:39 PM
Concert Pharmaceuticals just posted positive topline results for it's drug CTP-543 in treating alopecia areata (balding due to autoimmunity, on the disease list). CTP-543 is a Jak1/Jak2 inhibitor. Leronlimab downregulates Jak1, Jak2 and Jak3 which is also implicated in alopecia areata.
The exhibited side effects of CTP-543 are mainly due to immunosuppression. Of course leronlimab does not have the problem of immunosuppression.
https://finance.yahoo.com/news/concert-pharma...00313.html
The exhibited side effects of CTP-543 are mainly due to immunosuppression. Of course leronlimab does not have the problem of immunosuppression.
https://finance.yahoo.com/news/concert-pharma...00313.html
(18)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼